ECRI’s new headquarters features an independent medical device evaluation laboratory, an environmental lab, and accident and forensic investigation lab, multi-use, high-tech meeting rooms, open collaboration areas, and flexible workstations. The building’s third level, which has yet to be built out, is being envisioned as a hub for healthcare innovation, a place where local healthcare organizations with similar goals can collaborate on healthcare advancements.

Philadelphia-based Irwin & Leighton were the contractors on the building project that was designed by Meyer Architecture+Interiors. The building officially opened on April 19, 2022, with a formal ribbon cutting ceremony.

About ECRI
ECRI is an independent, nonprofit organization improving the safety, quality, and cost-effectiveness of care across all healthcare settings. With a focus on patient safety, evidence-based medicine, and health technology decision solutions, ECRI is respected and trusted by healthcare leaders and agencies worldwide. Over the past fifty years, ECRI has built its reputation on integrity and disciplined rigor, with an unwavering commitment to independence and strict conflict-of-interest rules.

ECRI is the only organization worldwide to conduct independent medical device evaluations, with labs located in North America and Asia Pacific. ECRI is designated an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality. ECRI and the Institute for Safe Medication Practices PSO is a federally certified Patient Safety Organization as designated by the U.S. Department of Health and Human Services. The Institute for Safe Medication Practices (ISMP) formally became an ECRI Affiliate in 2020. Marcus Schabacker, MD, PhD, President and CEO of ECRI, has been recognized by the Philadelphia Business Journal as a Healthcare Leader in 2021.

Back to HCB News

Business Affairs Homepage